Novo Nordisk No - Search News

Alzheimer's disease, Ozempic and Novo Nordisk

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in diabetes patients.

U.S. News & World Report · 9h

Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes

By Dennis Thompson HealthDay Reporter THURSDAY, Oct. 24, 2024 (HealthDay News) -- Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.

Bloomberg on MSN · 10h

Novo’s Ozempic Linked to Reduced Alzheimer’s Diagnoses

Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s effects in diseases beyond type 2 diabetes and obesity.

FDA, Ozempic and Novo Nordisk

Yahoo · 22h

Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes treatment Ozempic,

CNBC on MSN · 1d

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

The Danish drugmaker Novo Nordisk contends that semaglutide, the active ingredient in Ozempic and Wegovy, is too complex for those manufacturers to make safely.

Business Insider · 6h

Novo Nordisk asks FDA to ban cheap copies of Wegovy, Ozempic, CNBC reports

Novo Nordisk (NVO) has asked the FDA to ban cheap copies of its weight loss drugs Wegovy and Ozempic, arguing they pose safety risks,

1don MSN

Novo Nordisk Lashes Out at Wegovy Copycats. What it Means for Hims & Hers.

The Danish drugmaker asked the agency to put semaglutide, the active ingredient in Wegovy and Ozempic, on a list of drugs ...

ENDPOINTS NEWS10h

Novo Nordisk petitions FDA to stop semaglutide compounding over safety risks

Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...

Novo Nordisk: Be Cautious About Buying The Dip

Novo Nordisk faces competition from Eli Lilly in new therapeutic areas. Read why I rate NONOF stock as a hold.

GlobalData on MSN2d

Novo Nordisk plans label expansion for Rybelsus following Phase III win

The oral semaglutide reduced the occurrence of major adverse cardiovascular events (MACE) by 14% in patients with T2D.

BioSpace7h

Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’

The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo ...

11d

3 No-Brainer Growth Stocks to Buy in October

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Novo Nordisk: Time To Stay Calm Amid The Recent Plunge (Rating Upgrade)

Novo Nordisk faces growth deceleration but shows promise. Learn more about NVO stock and why its risk/reward profile may ...

Armed robbery in Revesby1d

Novo Nordisk Funds DKK 17M for Structural Facility

Enzymes are core components of many biotechnological solutions. Understanding enzymes' structure-function relationship will ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results